Impact of myo-inositol treatment in women with polycystic ovary syndrome in assisted reproductive technologies. Treatment of infertility in women with polycystic ovary syndrome: approach to clinical practice. Inositols' importance in the improvement of the endocrine-metabolic profile in PCOS. Wojciechowska A, Osowski A, Jóźwik M, Górecki R, Rynkiewicz A, Wojtkiewicz J. The 40: 1 myo-inositol/D-chiro-inositol plasma ratio is able to restore ovulation in PCOS patients: comparison with other ratios. The inositols and polycystic ovary syndrome. basic differences between d-chiro and myo-inositol. PCOS and inositols: controversial results and necessary clarifications. Monastra G, Vucenik I, Harrath AH, et al. The feasibility of a diet which enhances inositol availability. Moroni RF, Cazzaniga E, Palestini P, Sculati M. Effects of three treatment modalities (diet, myoinositol or myoinositol associated with D-chiro-inositol) on clinical and body composition outcomes in women with polycystic ovary syndrome. Le Donne M, Metro D, Alibrandi A, Papa M, Benvenga S. Inositols Depletion and Resistance: Principal Mechanisms and Therapeutic Strategies. Lepore E, Lauretta R, Bianchini M, Mormando M, Di Lorenzo C, Unfer V. PCOS (Polycystic Ovary Disease) and Diabetes. Experts’ opinion on inositols in treating polycystic ovary syndrome and non-insulin dependent diabetes mellitus: a further help for human reproduction and beyond.
Facchinetti F, Appetecchia M, Aragona C, et al.
0 kommentar(er)
